Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191895
Max Phase: Preclinical
Molecular Formula: C31H33N3O8
Molecular Weight: 575.62
Associated Items:
ID: ALA5191895
Max Phase: Preclinical
Molecular Formula: C31H33N3O8
Molecular Weight: 575.62
Associated Items:
Canonical SMILES: C/C=C(/C)C(=O)OC[C@H]1c2c(c(O)c(C)c3c2OCO3)C[C@H]2[C@H]3C4=C(C[C@@H]([C@H](C#N)N12)N3C)C(=O)C(C)=C(OC)C4=O
Standard InChI: InChI=1S/C31H33N3O8/c1-7-13(2)31(38)40-11-21-22-16(26(36)15(4)29-30(22)42-12-41-29)9-19-24-23-17(25(35)14(3)28(39-6)27(23)37)8-18(33(24)5)20(10-32)34(19)21/h7,18-21,24,36H,8-9,11-12H2,1-6H3/b13-7-/t18-,19-,20-,21-,24-/m0/s1
Standard InChI Key: IQJUBXHJLWZKIQ-VUDUHCEQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 575.62 | Molecular Weight (Monoisotopic): 575.2268 | AlogP: 2.55 | #Rotatable Bonds: 4 |
Polar Surface Area: 138.63 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.29 | CX Basic pKa: 3.15 | CX LogP: 3.71 | CX LogD: 3.71 |
Aromatic Rings: 1 | Heavy Atoms: 42 | QED Weighted: 0.32 | Np Likeness Score: 2.38 |
1. Fang Y, Li H, Ji B, Cheng K, Wu B, Li Z, Zheng C, Hua H, Li D.. (2021) Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification., 210 [PMID:33333398] [10.1016/j.ejmech.2020.113092] |
2. Yokoya M, Yamazaki-Nakai M, Nakai K, Sirimangkalakitti N, Chamni S, Suwanborirux K, Saito N.. (2023) Transformation of Renieramycin M into Renieramycins T and S by Intramolecular Photoredox Reaction of 7-Methoxy-6-methyl-1,2,3,4-tetrahydroisoquinoline-5,8-dione Derivatives., 86 (1.0): [PMID:36631738] [10.1021/acs.jnatprod.2c00974] |
Source(1):